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Gene Mapping via Bulked Segregant RNA-Seq (BSR-Seq)
Abstract
Bulked segregant analysis (BSA) is an efficient method to rapidly and efficiently map genes responsible for
mutant phenotypes. BSA requires access to quantitative genetic markers that are polymorphic in the mapping
population. We have developed a modification of BSA (BSR-Seq) that makes use of RNA-Seq reads to
efficiently map genes even in populations for which no polymorphic markers have been previously identified.
Because of the digital nature of next-generation sequencing (NGS) data, it is possible to conduct de novo SNP
discovery and quantitatively genotype BSA samples by analyzing the same RNA-Seq data using an empirical
Bayesian approach. In addition, analysis of the RNA-Seq data provides information on the effects of the
mutant on global patterns of gene expression at no extra cost. In combination these results greatly simplify
gene cloning experiments. To demonstrate the utility of this strategy BSR-Seq was used to clone the glossy3
(gl3) gene of maize. Mutants of the glossy loci exhibit altered accumulation of epicuticular waxes on juvenile
leaves. By subjecting the reference allele of gl3 to BSR-Seq, we were able to map the gl3 locus to an ∼2 Mb
interval. The single gene located in the ∼2 Mb mapping interval whose expression was down-regulated in the
mutant pool was subsequently demonstrated to be the gl3 gene via the analysis of multiple independent
transposon induced mutant alleles. The gl3 gene encodes a putative mybtranscription factor, which directly or
indirectly affects the expression of a number of genes involved in the biosynthesis of very-long-chain fatty
acids.
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Abstract
Bulked segregant analysis (BSA) is an efficient method to rapidly and efficiently map genes responsible for mutant
phenotypes. BSA requires access to quantitative genetic markers that are polymorphic in the mapping population. We have
developed a modification of BSA (BSR-Seq) that makes use of RNA-Seq reads to efficiently map genes even in populations
for which no polymorphic markers have been previously identified. Because of the digital nature of next-generation
sequencing (NGS) data, it is possible to conduct de novo SNP discovery and quantitatively genotype BSA samples by
analyzing the same RNA-Seq data using an empirical Bayesian approach. In addition, analysis of the RNA-Seq data provides
information on the effects of the mutant on global patterns of gene expression at no extra cost. In combination these
results greatly simplify gene cloning experiments. To demonstrate the utility of this strategy BSR-Seq was used to clone the
glossy3 (gl3) gene of maize. Mutants of the glossy loci exhibit altered accumulation of epicuticular waxes on juvenile leaves.
By subjecting the reference allele of gl3 to BSR-Seq, we were able to map the gl3 locus to an ,2 Mb interval. The single
gene located in the ,2 Mb mapping interval whose expression was down-regulated in the mutant pool was subsequently
demonstrated to be the gl3 gene via the analysis of multiple independent transposon induced mutant alleles. The gl3 gene
encodes a putative myb transcription factor, which directly or indirectly affects the expression of a number of genes
involved in the biosynthesis of very-long-chain fatty acids.
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Introduction
Next generation sequencing (NGS) technologies [1–5] are
revolutionizing biology much as PCR technologies did at the
end of the last century. Adaptations of NGS technologies are
proving to be superior to alternative technologies for genome-wide
measurements of mRNA, small RNAs, transcription-factor
binding sites, DNA methylation, chromatin structure and
structural variation [1,2,6,7].
The mapping of the genetic determinants of phenotypic
variation is often a key step in the characterization of mutants
and QTLs. In complex genomes mapping remains a non-trivial
process. Bulked segregant analysis (BSA) is a method used to
rapidly identify genetic markers linked to a genomic region
associated with the selected phenotype [8]. Genetic linkage
between markers and the causal gene is determined via
quantification of allelic frequencies of genetic markers in the pools
(bulks) of organisms that do and do not express a given phenotype.
A wide variety of genetic markers have been used for BSA. The
only requirement is that selected markers provide quantitative
measurements of allelic frequencies. Examples include hybridiza-
tion-based markers such as Restriction Fragment Length Poly-
morphisms (RFLPs) [8], Single Feature Polymorphisms (SFPs) [9],
and Diversity Array Markers (DArTs) [10], as well as PCR-based
methods such as Random Amplified Polymorphic DNAs (RAPDs)
[11], Simple Sequence Repeats (SSRs, or microsatellites) [12–14],
Amplified Fragment Length Polymorphisms (AFLPs) [15,16],
Cleaved Amplified Polymorphic Sequence (CAPS) for detecting
Single Nucleotide Polymorphisms (SNPs) [17] and Sequenom
SNP-typing [18]. More recently the efficiency of BSA has been
greatly enhanced by the application of sequence-based markers
such as restriction-site associated DNA (RAD) markers [19] and
whole genome sequencing [20]. Both of these technologies fail to
select against repetitive genomic sequences that are not typically
useful in mapping experiments. In addition, even given the
extraordinary advances in the throughput of NGS, whole genome
sequencing remains expensive for large genomes, making it less
suitable for mapping experiments that include many mutants.
One of the most widely adopted adaptations of NGS technology
is RNA-Seq [21–27], which enables the comparative quantifica-
tion of gene expression in, for example, various genotypes. RNA-
Seq relies on the principle that read counts for each transcript
from the NGS data reflects relative transcript concentrations. This
relative quantification is reproducible and highly accurate [2,25–
28]. RNA-Seq reads can also be mined for DNA sequence
polymorphisms such as single nucleotide polymorphisms (SNPs)
[29,30], which can be converted into genetic markers [18,31–34].
We combined the power of BSA with the ease of RNA-Seq and
appropriate statistical procedures into a new genetic mapping
strategy called BSR-Seq (Bulked Segregant RNA-Seq). As a proof
of concept, RNA-Seq was conducted on mutant and non-mutant
pools of maize seedlings segregating for gl3, a recessive mutant
involved in the accumulation of epicuticular wax [35,36]. After
quantifying allele frequency via read counts in RNA-Seq,
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a Bayesian-based BSA approach was developed to map gl3. The
resulting mapping data were consistent with previous mapping
results obtained via independent approaches. The mapping results
were combined with transcriptional profiles from the RNA-Seq
data to facilitate the cloning of gl3. The successful cloning of gl3
demonstrates the utility of BSR-Seq.
Results
An individual heterozygous for the gl3-ref allele was self-
pollinated to generate a segregating F2 population. Consistent
with expectations based on the fact that the gl3 mutant is recessive,
,25% of the F2 seedlings expressed the mutant phenotype. RNA
samples from mutant and non-mutant individuals from this F2
population were combined into two separate pools and subjected
to RNA-Seq (Figure 1, Methods). One lane of an Illumina GAIIx
flowcell was used for each of the two RNA samples; each lane
yielded more than 13 million 75-bp single-end reads (Table S1).
Reads that had been trimmed based on quality scores were
mapped to the B73 maize reference genome using GSNAP that
allows intron-spanning alignments (Methods). In total, 53.3% and
54.9% of the trimmed reads from the mutant and non-mutant
pools were uniquely mapped to the reference genome, respective-
ly. Of these uniquely mapped reads, 89.5–90.5% were located in
high-confidence gene models [37]. In total, 76% (24,757/32,540)
of the gene models had read(s) from at least one of the RNA-Seq
datasets (Table S1).
RNA-Seq of gl3 vs. Non-mutant Siblings
An RNA-Seq analysis was conducted on the 16,726 maize genes
for which at least 40 uniquely mapped reads were obtained from
the combined mutant and non-mutant pools. In this analysis 1,095
genes were differentially expressed between the two pools
(FDR=0.1%; and having an absolute log2 fold change of .0.8;
Figures S1–4; Tables S2 and S3).
Mapping of gl3 via BSR-Seq
To map the gl3 gene, polymorphic SNPs that could serve as
genetic markers were identified in the mapping population using
the RNA-Seq data. By pooling RNA-Seq data from the two
samples statistical power was increased and more than 64,000
high-confidence SNPs were discovered (Tables S4 and S5).
We next sought to identify SNPs that linked to the causal gene.
In the absence of allele-specific expression (ASE), the two alleles of
a given SNP site should be detected in approximately equal
numbers of RNA-Seq reads when considering both pools of RNA-
Seq data. Only one allele of a SNP that is completely linked to the
causal gene should be present among the RNA-Seq reads from the
mutant pool. In practice, however, as a consequence of ASE and
sampling bias, particularly for genes that are expressed at low
levels, only a single allele of many SNPs are detected in the mutant
pool. To correct for these and other biological and technical
artifacts, we used an empirical Bayesian approach to estimate
linkage probability that is the probability of a SNP exhibiting
complete linkage disequilibrium with the causal gene (Methods).
The linkage probability of each SNP was plotted against its
physical coordinate in the reference genome as shown in Figure 1B.
SNP markers having high probabilities of being linked to the gl3
gene clustered on the long arm on chromosome 4. No SNP
markers with high linkage probability were observed on any other
chromosomes. This BSR-Seq-based localization of the gl3 gene is
consistent with previous mapping results obtained using in-
dependent approaches [18]. To narrow down the interval within
which the gl3 gene is located, chromosome 4 was scanned using
a window of a fixed number of SNPs (N=50) and a step size of
5 SNPs. The median linkage probability across the 50 SNPs of
each window was plotted against the physical midpoint of each
window (Figure 1D). A strong peak, indicating a high probability
of complete linkage disequilibrium with the gl3 gene, was observed
at physical position ,183–194 Mb of the B73 reference genome.
The top 10 windows with the highest median linkage probability
were located at physical position ,183.5–185.2 Mb.
The Cloning and Validation of gl3
To validate the mapping results from the BSR-Seq experiment
we cloned the gl3 gene. The high copy Mu transposon system is
widely used as a mutagenic agent in forward genetic mutant
screens of maize [38]. Using this transposon system we generated
six additional gl3 mutant alleles (Methods). The genomic
sequences flanking the Mu transposons in maize stocks carrying
each of these newly isolated gl3-Mu alleles were independently
determined using the DLA-454 method [39]. We expected that
most, if not all, of these independent alleles would contain a Mu
transposon insertion site within the gl3 gene. Among the 48 genes
(4a.53 B73 filtered gene set) located in the ,2 Mb interval
identified by the BSR-Seq experiment, two genes contained $3
independent Mu insertions. Based on the RNA-Seq experiment,
one of these genes, GRMZM2G162434, was significantly down-
regulated in the mutant pool as compared to the non-mutant
pool (Figure 2A). Using PCR primers specific to the inverted
repeats of Mu transposons and to the gl3 candidate gene
(GRMZM2G162434) it was possible to amplify Mu insertions
from three of the six gl3 alleles derived from the forward Mu
mutant screen. In addition, two previously identified EMS-
induced alleles of gl3 contain the typical EMS-induced G/C-to-
A/T transitions [40] in GRMZM2G162434; both of these
transitions generated premature stop codons (Figure 2B). Se-
quence analysis of the reference allele, gl3-ref, originally reported in
1928 [35], appears to contain a large insertion or other
rearrangement between 430–758 nt of the coding region of
GRMZM2G162434 that can not be PCR amplified (Figure 2B).
Consistently, very few RNA-Seq reads were obtained 39 of this
region (Figure 2A).
Based on comparisons to the Arabidopsis and rice genomes, the
gl3 gene is predicted to encode an R2R3 type myb transcription
factor [41] that contains two Myb DNA-binding domains. The
GL3 protein is most similar to the Arabidopsis proteins MYB30
and MYB60. Consistent with the phenotype of the gl3 mutant, the
Arabidopsis Myb30 gene regulates the biosynthesis of very-long-
chain fatty acids [42], which are precursors to epicuticular waxes.
Considering 30 maize candidate genes implicated in the
accumulation of epicuticular waxes, including maize orthologs of
Arabidopsis epicuticular wax genes (Methods), 22 accumulated at
least 40 read counts across the two pools. Of these 22 genes, 6 are
differentially expressed in the gl3 mutant as compared to non-
mutant siblings (3 up-regulated, 3 down-regulated) (Table S6).
Collectively, these results demonstrate that GRMZM2G162434
is the gl3 gene. Because GRMZM2G162434 is located within the
,2 Mb interval defined by the BSR-Seq experiment, these results
demonstrate the utility of BSR-Seq for gene mapping and cloning.
Discussion
Advantages of BSR-Seq
Evolving NGS technologies are powerful tools for answering
biological questions. For example, RNA-Seq is a highly accurate
and robust approach for quantifying gene expression. Here we
have reported a BSA-based mapping strategy (BSR-Seq) that relies
Bulked Segregant RNA-Seq (BSR-Seq)
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Figure 1. BSR-Seq. A. A flowchart of BSR-Seq experimental design. B. The physical position of each SNP marker (x-axis) was plotted versus the
probability of each SNP marker being in complete linkage disequilibrium with the causal gene (y-axis). C. gl3 mutants (the gl3-ref allele) express
a glossy phenotype due to altered accumulation of epicuticular waxes. Water is sprayed on seedlings to distinguish mutant (gl3-ref/gl3-ref) from non-
mutant (gl3-ref/+ or +/+). D. Chromosome 4 was scanned by using a window containing 50 SNPs with a step size of 5 SNPs. Within each window, the
median linkage probability obtained from a Bayesian BSA analysis across all the 50 SNPs was determined and was plotted against the middle physical
position of the window.
doi:10.1371/journal.pone.0036406.g001
Bulked Segregant RNA-Seq (BSR-Seq)
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on RNA-Seq data. For relatively small genomes that contain little
repetitive DNA (e.g., Caenorhabditis elegans or Arabidopsis), it is
feasible to conduct BSA using whole genome shotgun (WGS)
sequencing [20,43]. However, for mapping mutants in large
genomes (e.g., maize and humans), WGS is not cost efficient. In
these species BSR-Seq is both inexpensive and efficient.
BSR-Seq provides not only the map position of a gene
responsible for a mutant phenotype but also the effects of such
a mutant on global patterns of gene expression. The expression
patterns of genes within the mapping interval can be used to
prioritize candidate genes based on the fact that the causal gene
will often be down-regulated in the mutant pool as compared to
the non-mutant pool. In addition, this strategy yields a collection
of polymorphic SNPs that are tightly linked to the mutant. These
SNPs could be used to fine map the mutant or clone the affected
gene via chromosome walking. Hence, BSR-Seq is not only an
efficient strategy for mapping genes, but also yields other data that
facilitate gene cloning.
Potential Problems and Strategies for the Improvement
We have used BSR-Seq to successfully map five genes
(unpublished results). The size of the mapping interval obtained
from a BSR-Seq experiment depends on the number of individuals
included in the mutant and non-mutant pools, the sequencing
depth, and the density of polymorphisms in the mapping
population. For each parameter more is better. In the reported
proof-of-principle experiment designed to map the gl3 locus, we
included only ,30 individuals in each pool and generated only
one lane of GAIIx data for each pool (,13 M reads/pool). Maize
is a highly polymorphic species whose transcriptome contains .4
SNPs/kb [30]. Given these conditions it was possible to map the
gl3 gene to an interval of only a few megabases. In the gl3 BSR-Seq
experiment, the haplotype of either parent was not used for the
BSR-Seq analysis.
The mutants used to map the gl3 gene are fully recessive and
easily distinguished from non-mutants. The accurate classification
of mutant and non-mutant individuals is not always so straightfor-
ward. The inclusion of non-mutants in the mutant pool would
negatively impact a BSR-Seq experiment. In our Bayesian analysis
approach, a SNP is classified as having a high probability of being
in complete linkage disequilibrium with the causal gene only if it is
‘‘fixed’’ in the mutant pool, i.e., the mutant pool contains only
a single allele. This criterion is too strict if non-mutants are likely
to be inadvertently included in the mutant pool as a consequence
of misclassification errors. To adapt our approach for the existence
of such errors, a gene could still be classified as having a high
probability of being in complete linkage disequilibrium with the
causal gene even if it exhibited some defined (but low) level of
Figure 2. Gene structure of the gl3 gene and lesions of its mutant alleles. A. RNA-Seq reads shown in the Integrative Genomics Viewer. Blue
indicates reads that have a forward orientation relative to the reference genome; red indicates reverse orientation. B. Based on the supporting ESTs
and the annotation from the gene models, the gl3 gene contains only a single exon. All six lesions associated with gl3 mutant alleles are located in
the coding region. They include Mu insertion alleles (a: gl3-93-4700-5; b: gl3-93-4700-6; c: gl3-93B111), EMS alleles (1: gl3-AEW-A632-363-EMS,
premature stop at position 171 nt in coding region (G-.A); 2: gl3-94-1001-326-EMS, premature stop at position 358 nt in coding region (C–T)) and the
reference allele (3: gl3-ref, insertion or rearrangement at 430–758 nt of the coding region).
doi:10.1371/journal.pone.0036406.g002
Bulked Segregant RNA-Seq (BSR-Seq)
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apparent recombination with the causal gene. The inadvertent
inclusion of a small number of mutants in the non-mutant pool (as
would be the case for an incompletely recessive mutant) is less
likely to seriously impact mapping accuracy.
A mutant that influences the regulation of allele-specific
expression [44–47] has the potential to generate false-positive
SNPs in a BSR-Seq mapping experiment. To avoid these
problems the second stage of our analysis focuses on only that
subset of SNPs whose read counts in the mutant and non-mutant
pools suggest that they co-localize with the causal gene (Methods).
Using this two-stage approach, we did not observe any SNPs that
incorrectly exhibited a high probability of linkage to the gl3 gene
outside of chromosome 4.
In principle, BSR-Seq could be extended to other applications,
including the mapping of genes defined by dominant mutants and
major QTL loci. In this case the analysis would, however, require
some modifications. A related situation would be the mapping of
a causal gene whose expression is influenced by genetic modifiers.
We anticipate that BSR-Seq could be adapted to enable the
simultaneous mapping of the causal gene and the modifiers.
One of the advantages of BSR-Seq is that it yields not only
mapping data, but also information on the effects of the mutant on
global patterns of gene expression. Of the 1,095 significantly
differentially expressed genes in the RNA-Seq experiment, 446
were down-regulated and 633 were up-regulated in the gl3
mutants as compared to their non-mutant siblings, yielding a ratio
of down-regulated to up-regulated genes of 0.7 (Table S7). In
contrast, considering only the genes on chromosome 4 (which
contains the gl3 gene) this ratio is 1.6, which is significantly
higher than that of all other chromosomes (Pearson’s Chi-square
test, x2 = 22.11, df = 1, p-value = 2.58e206). And within the 180–
195 Mb interval of chromosome 4 that contains the gl3 gene, this
ratio is 3.3 (10:3). This bias likely reflects the combined effects of
downwardly biased read counts in gene linked to gl3 due to
polymorphisms in expressed genes in coupling with gl3. Hence,
interpretation of differential gene expression within the mapping
interval must be treated with caution.
During BSR-Seq, RNA-Seq reads are used for both the
identification and quantification of SNPs and tests for differential
gene expression. This BSR-Seq experiment made use of
unreplicated RNA-Seq data. The lack of replication would not
be expected to adversely affect the mapping results. On the other
hand, to accurately identify differentially expressed genes it would
be desirable to have replicated RNA-Seq data.
The decision of which tissue from which to collect RNA-Seq
data does not seriously impact the genetic mapping function of
BSR-Seq. It is not necessary that the causal gene be expressed in
the samples used for BSR-Seq. This is because SNPs in all genes
located near the causal gene and that are expressed in these
samples can be used as markers to map the causal gene. On the
other hand, one of the advantages of BSR-Seq over other mapping
strategies is that it also has the potential to provide expression data.
Hence, it would be ideal to extract the RNA from a tissue in which
the causal gene is expressed. This would most likely be the case if
a tissue in which the mutant phenotype is evident is selected for
BSR-Seq.
Both WGS-BSA and BSR-Seq depend on access to a reference
genome and both approaches are affected by the quality of that
reference genome and the degree of structural variation within the
species being analyzed. Mis-assemblies in the reference genome
and copy number variation (CNV) between the genomes present
in the mapping population and the reference genome could
potentially negatively influence mapping success. Even so,
although the B73 reference genome (version 1) contained a major
assembly error in the vicinity of gl3 (data not shown), and maize
contains extremely high levels of CNV [48] we were able to
successfully map gl3 using BSR-Seq.
Methods
Genetic Materials
A plant carrying a gl3-ref allele in a non-B73 genetic background
was crossed to the inbred line B73. The gl3-ref allele was obtained
from Donald Robertson, Iowa State University [36]. A single
progeny was self-pollinated to generate a segregating F2 popula-
tion for use in the RNA-Seq experiment. Additional alleles were
generated via direct Mutator transposon tagging experiments via
Crosses 1: Gl3/Gl3 (Mu stock) x gl3-ref/gl3-ref. Two existing EMS-
(ethylmethane sulphonate) induced alleles of gl3 (gl3-AEW-A632-
363-EMS and gl3-94-1001-326-EMS) generated by Gerry Neuffer
were used for verification of the candidate gl3 gene. Confirmed gl3
mutant alleles will be deposited in the maize genetics stock center.
RNA Isolation and RNA-Seq
F2 seeds were grown at 25uC for six days (2-leaf stage), at which
time the lower leaves of 32 mutants (gl3-ref/gl3-ref) and 31 non-
mutant siblings (gl3-ref/Gl3-B73 or Gl3-B73/Gl3-B73) were
collected and separately pooled for RNA extraction (RNeasy mini
kit, Qiagen, Chatsworth, CA) followed by treatment with DNase I.
Sequencing libraries were constructed using the Illumina mRNA-
Seq sample preparation kit (Solexa/Illumina, Catalog no. RS-100-
0801). The resulting libraries were sequenced on an Illumina
Genome Analyzer II with 75 cycles, resulting in 75 bp single end
reads (GenBank accession no. SRA049037).
Mapping RNA-Seq Reads
Raw RNA-Seq reads were trimmed to remove low-quality
nucleotides via an in-house trimming script. GSNAP (Genomic
Short-read Nucleotide Alignment Program, version 2010-03-09)
[49], which allows gap alignment including intron-spanning
alignment, was used to map trimmed reads to the B73 reference
genomes (B73ref_v1) [37], the mitochondrial genome (Genbank
acc#: AY506529.1) and the chloroplast genome (Genbank acc#:
X86563.2). Reads that uniquely mapped to B73ref_v1 with #2
mismatches every 36 bp (a site with insertions or deletions was
counted as a mismatch) were used for further analyses. The read
number of each gene model (Refgen1, 4a.53) [37] was computed
based on the coordinates of mapped reads. A read was counted if
any portion of that read’s coordinates were included within a gene
model.
SNP Calling and Filtration
Sequence variants identified by GSNAP were further filtered to
identify SNPs for BSR-Seq. The alignments of uniquely mapped
reads passing the filtering criteria from the mutant and non-
mutant data sets were merged for SNP discovery using the
following rules. Validated SNP site must have two and only two
SNP-types. Reads from these two SNP-types must account for
$90% of the total reads that align to this SNP site. Each SNP-type
must have$3 reads (quality score of SNP base$15) and the reads
account for $20% of the total reads on that SNP site, which
stringently controls for potential false SNP discovery derived from
sequencing errors or paralogs. The SNP discovery pipeline is
downloadable (http://schnablelab.plantgenomics.iastate.edu/
software). In addition, we previously identified a set of genomic
sites that are either sequencing errors in the B73 reference genome
or paramorphisms [50] (data not shown). These sites were further
filtered from discovered SNPs, followed by the allele-specific
Bulked Segregant RNA-Seq (BSR-Seq)
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quantification on these filtered SNP sites for both mutants and
non-mutants. To get a set of SNPs for the BSR-Seq analysis, at
each SNP we required that at least five sequencing reads in both
the mutant pool and the non-mutant pool and both alleles have at
least one read in the non-mutant pool.
Identification of SNP Markers Tightly Linked to the
Mutant Gene
An empirical Bayesian approach was used to estimate, for each
SNP, the conditional probability of no recombination between the
SNP marker and the causal gene in the mutant pool, given the
SNP allele-specific counts.








where ‘‘no R’’ and ‘‘R’’ denote no recombination and re-
combination, respectively, between the SNP and the causal gene






In equations (1) and (2), P(noR) is the prior probability that there
is no recombination between a randomly selected SNP and the
causal gene in the mutant pool, and P(R) is the prior probability
that there is recombination between a randomly selected SNP and
the causal gene in the mutant pool. Let d denote the distance in
Morgans between any randomly selected SNP and the causal
gene. If we assume a uniform prior distribution across the genome
for the causal gene location, it follows that the prior for d is
uniform for values of d near zero. For a given distance d, we use
Haldane’s mapping function to compute the prior probability of






where N denotes the number of plants in the mutant pool. Note
that q(d) quickly converges to zero as d moves away from zero.
Thus, we can find the approximate expected value of q(d) by
integrating the product of q(d) and the prior density of d in
a neighborhood of zero (0 to 20 cM, for example). This expected
value serves as P(noR) the prior probability of no recombination
between the SNP and the causal gene in the mutant pool. The
prior probability of some recombination between a randomly
selected SNP and the causal gene is given by P(R)~1{P(noR).
Next consider P(x1,x2jnoR), the conditional probability of the
allele counts at a SNP in the mutant pool, given no recombination
between the SNP and the causal gene in the mutant pool. Because
each plant in the mutant pool contains two copies of the mutant
allele and zero copies of the wildtype allele, no recombination
implies that all SNP alleles coupled with the mutant allele. Thus,
P(x1,x2jnoR)~1 if fx1,x2g~f0,ngand 0 otherwise, where n
denotes the total number of reads for the SNP. By expression (1), it
is clear that P(noRjx1,x2)~0 if P(x1,x2jnoR)~0 i.e., if
fx1,x2g=f0,ng.
The final probability needed for the computation of (1)
isP(x1,x2jR). To compute the probability, we condition on the
total number of reads for the SNP (n~x1zx2) and assume that
x1 has a binomial distribution with n trials and success probability
p. Given that there is some recombination between the SNP and
the causal gene, we know that it is possible for RNA sequences in
the mutant pool to contain both SNP alleles. However, we cannot
know precisely the relative probability of each allele. In other
words, the success probability p is unknown and likely to vary from
SNP to SNP. Thus, we require a prior distribution for p to provide
an adequate representation of the possible values for the relative
frequency of each allele. While a variety of choices are possible, we
choose to take advantage of the large quantity of SNP data in the
non-mutant pool to generate an empirical prior distribution. In
particular, we use the observed non-zero relative frequencies of
alleles at each SNP in the non-mutant pool to obtain the prior
distribution for p. It is then straightforward to compute P(x1,x2jR)
as the expected value of P(x1,x2jR,p) with respect to this empirical
prior distribution.
Once all the component probabilities have been obtained, it is
straightforward to computeP(noRjx1,x2)for each SNP in the
mutant pool. These posterior probabilities can then be used to
identify regions likely to contain the causal gene. However, the
computation of these posterior probabilities makes little use of the
data from the non-mutant pool. We can gain additional
information about the likely location of the causal gene by more
fully utilizing the non-mutant data.
In traditional BSA, DNA sequences that completely linked to
the causal gene are expected to exhibit 1:2 ratio of mutant to
wildtype alleles in the non-mutant pool. However, in BSR-Seq
allele frequencies are measured at the RNA level. There is no
guarantee that the relative frequency observed in RNA-Seq reads
will match the relative frequency at the DNA level. In addition, the
read counts themselves are subject to biological and technical
variation. To address these issues, we use the RNA-Seq data to
estimate, for each SNP, P(pmƒ
1
2
jwm,w), where pm is the
proportion of a mutant allele read at the SNP in the non-mutant
pool, wm is the observed number of reads in the non-mutant pool
that match the mutant allele, and w is the total number of reads at
the SNP in the non-mutant pool. The value of 1
2
is selected here
because we believe it is reasonable to assume that the mutant allele
will be less probable than the wildtype allele for a SNP near the
causal gene in the non-mutant pool, given that the expected
relative frequency of the mutant allele at the DNA level is only half










P(wm,wjpmƒ 12 )P(pmƒ 12 )
P(wm,w)
ð3Þ
The identity of the mutant allele is determined by the most
frequent allele in the mutant pool. This will be correct for SNPs
near the causal gene and irrelevant for other SNPs that will be
ruled out as candidates by our calculation of P(noRjx1,x2). As in
our calculation of P(noRjx1,x2), we use the observed relative
frequencies of alleles at each SNP in the non-mutant pool to
obtain a prior distribution forpm. Each of the probabilities in (3)
can be easily obtained by computing expectation with respect to
this empirical prior.
Once we have computed P(noRjx1,x2) and P(pmƒ 12 jwm,w)
for each SNP, we compute the product of these probabilities (final
probabilities) for each SNP to identify SNPs likely to be tightly
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linked to the causal gene. Only SNPs with high values of both
P(noRjx1,x2) and P(pmƒ 12 jwm,w) will have a large product.
SNPs for which either P(noRjx1,x2)or P(pmƒ 12 jwm,w) is small
will be ruled out.
To obtain the genomic region(s) that are more likely linked to
the causal gene, we scanned the whole genome by sliding windows
with fixed number of SNPs (N= 50) and with a step size of 5 SNPs.
In each window, a median of the final probabilities of all the SNPs
was determined as the ‘‘window linkage probability’’. The
windows with the highest ‘‘window linkage probability’’ are the
regions close to the causal genes.
Identify differentially expressed genes via Fisher’s exact
test. The Fisher’ exact test was used to test the null hypothesis
that the proportions of reads of a given gene among the total reads
uniquely mapped to the reference genome are not different
between the mutants and the non-mutants. Only genes with at
least 40 total reads from both genotypes were used to perform the
Fisher’ exact test. Absolute value of log2 mutant/non-mutant fold
change greater than 0.8 was used to further filter DE genes. The
transcripts were quantified by using normalized read counts plus 1.
The total number of uniquely mapped reads of each data set was
used for the normalization. The significantly expressed genes were
obtained with the additional false discovery control (false discovery
rate, FDR=0.1%) to account for multiple tests [51]. Because this
comparison did not include biological replication, statistically
significant variation can be a consequence of either biological or
technical variation in gene expression between the two samples.
Identification of Maize Genes Involved in the Epicuticular
Wax Pathway
The protein sequences of 13 Arabidopsis genes involved in
biosynthesis and secretion of plant cuticular wax were BLAST to
the maize protein database. The BLAST alignments of E-value ,
e250, .50% identity and .30% coverage were extracted. For
each Arabidopsis gene, we kept at most three best hits. Three
Arabidopsis genes (wsd1, mah1 and cer2) did not have homologs
identified in maize with the criteria. The best hit was extracted as
the homologous gene of each of these three. In total, 25 maize
homologous candidates were identified. With adding cloned maize
glossy genes that are not in the Arabidopsis homologous list, 30
maize genes that might involve in the epicuticular wax pathway
were obtained.
Supporting Information
Figure S1 Histogram of p-values for differential expres-
sion tests. Fisher’s exact test was used to test the null hypothesis
that expression of a given gene is not different between the two
groups. A p-value was obtained for each informative gene. The
distribution of p-values under the null hypothesis (no differential
genes existed) is a uniform distribution in the range of 0–1. More
than the expected number of p-values with small values indicates
significantly differentially expressed genes could be statistically
identified.
(DOC)
Figure S2 MA-similar plot. The MA-similar plot provides an
overview of the differential level between groups of the
comparison. Log2 fold change (y-axis) of each informative gene
was plotted against log2 of mean of expression (x-axis).
Significantly differentially expressed genes are highlighted in red.
(DOC)
Figure S3 Volcano plot. The volcano plot compares gene
expression patterns between two groups. Negative log10 p-values
from the differential expression test were plotted against the log2
fold change for each informative gene. Each dot represents a gene,
plotting with 20% transparency. The horizontal dash line indicates
the 0.1% FDR cutoff. The vertical green lines indicate the cutoffs
of log2 wildtype/mutant ratios equaling to -0.8 and 0.8.
(DOC)
Figure S4 Overview of differential expression in the
metabolic pathway in MapMan. MapMan (mapman.gabip-
d.org) provides a useful tool to visualize the alteration of gene
expression in the comparison. Differential expression in the
metabolic pathway was shown as an example. Each square
represents a transcript. The squares were color-coded by log2 fold
change between the gl3 non-mutant pool and the mutant pool
from the RNA-Seq data. The up- and down-regulated genes in the
mutant pool relative to the non-mutant pool were highlighted in
red and blue, respectively. More pathways can be explored by
feeding the data of Table S3 to the MapMan software.
(DOC)
Table S1 Summary of RNA-Seq data and alignments.
(DOC)
Table S2 Result of differential expression tests. Table S2
provides the detailed differential expression test result of genes
(4a53). Test was performed on the informative genes that are those
genes with at least 20 average reads across the two samples.
Description of each column in this table: N GeneID: gene ID; N
Ref: version of the reference genome; N Chr: chromosome; N Ori:
gene orientation (either forward (+) or reverse (2) strand); N Start:
the first physical position of the gene on the chromosome; N End:
the last physical position of the gene on the chromosome; N
ExonSize: total length of all the gene’s annotated exons; N
gl3mut: raw read counts for the gene of the sample of the gl3
mutant pool; N gl3wt: raw read counts for the gene of the sample
of the gl3 non-mutant pool; N gl3mut.RPKM: normalized read
counts of a given gene (‘‘RPKM’’ means reads per kb exonic
sequence per million uniquely mapped reads) in the sample of the
gl3 mutant pool; N gl3wt.RPKM: normalized read counts of
a given gene in the sample of the gl3 non-mutant pool; N
gl3wt:mut_log2FC: log2 of fold change between the gl3 non-
mutant pool and the mutant pool; N gl3wt:mut_pvalue: p_value
of the statistical test for differential expression of this gene between
the gl3 non-mutant pool and the mutant pool; N gl3wt:mut_q-
value: the corrected p-values (q_values) for differential expression
of this gene after correcting for multiple testing; N gl3wt:mut_sig:
the answer to the question ‘‘Is this gene significantly expressed?’’
The gene with the q_value smaller than 0.001 (FDR 0.1%) and
having an absolute log2 fold change of .0.8 was labeled with
‘‘yes’’. N description: description of genes.
(XLS)
Table S3 The expression test data to feed MapMan for
the pathway visualization. Table S3 contains two columns.
The first column is the transcript name; the second column is the
value of log2(fold-change). The transcripts without significantly
differential expression were assigned a value of zero.
(DOC)
Table S4 Summary of SNP discovery.
(DOC)
Table S5 Allele counts in the mutant pool and the non-
mutant pool. Table S5 provides the read counting information
for each of both alleles in the mutant and the non-mutant.
(XLS)
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Table S6 Expression summary of genes involved in the
biosynthesis of very-long-chain fatty acids.
(DOC)
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